Neuroprotection by dextromethorphan in acute experimental subdural hematoma in the rat

Journal of Neurotrauma

Volumn 13, Issue 2, 1996, Pages 79-84

  Duhaime, Ann Christine ^a,b   Gennarelli, Laura M ^a   Boardman, Chris ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

animal; dextromethorphan; excitotoxicity; experimental; head injury; neuroprotection; subdural hematoma

Indexed keywords

DEXTROMETHORPHAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEAD INJURY; MALE; NEUROTRANSMISSION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SUBDURAL HEMATOMA;

EID: 0029876024     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1996.13.79     Document Type: Article

References (25)

1. ALBERICO, A.M., WARD, J.D., ET AL. (1987). Outcome after severe head injury. Relationship to mass lesions, diffuse injury, and ICP course in pediatric and adults patients. J. Neurosurg. 67, 648-656.
2. ALBERS, G.W. (1990). Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia. Clin. Neuropharmacol. 13(3), 177-197.
3. BULLOCK, R., BUTCHER, S., ET AL. (1990). Changes in extracellular glutamate concentration after acute subdural haematoma in the rat-evidence for an "excitotoxic" mechanism? Acta Neurochir. Suppl. 51, 274-276.
4. BULLOCK, R., BUTCHER, S.P., ET AL. (1991). Correlation of the extracellular glutamate concentration with extent of blood flow reduction after subdural hematoma in the rat. J. Neurosurg. 74, 794-802.
5. CHEN, M.S., BULLOCK, R., ET AL. (1991). Ischemic neuronal damage after acute subdural hematoma in the rat: Effects of pretreatment with a glutamate antagonist. J. Neurosurg. 74, 944-950.
6. DURAIME, A.C. (1993). Exciting your neurons to death: Can we prevent cell loss after brain injury? Pediatr Neurosurg. 21, 117-123.
7. DUHAIME, A.C., GENNARELLI, L., ET AL. (1993), Experimental acute subdural hematoma: Variations on a theme. J. Neurotrauma 10(Suppl 1), S150.
8. DUHAIME, A.C., GENNARELLI, L.M., ET AL. (1994). Acute subdural hematoma: Is the blood itself toxic? J. Neurotrauma 11(6), 669-678.
9. FADEN, A.I. (1993). Comparison of single and combination drug treatment strategies in experimental brain trauma. J. Neurotrauma 10(2), 91-100.
10. FADEN, A.I., DEMEDIUK, P., ET AL. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244, 798-800.
11. GEORGE, C.P., GOLDBERG, M.P., ET AL. (1988). Dextromethorphan reduces neocortical ischemic damage in vivo. Brain Res. 440, 375-379.
12. GOLDBERG, M.P., PHAM, P., ET AL. (1987). Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture. Neurosci. Lett. 80, 11-15.
13. INGLIS, F., KURODA, Y., ET AL. (1992). Glucose hypermetabolism after acute subdural hematoma is ameliorated by a competitive NMDA antagonist. J. Neurotrauma 9(2), 75-84.
14. KURODA, Y., and BULLOCK, R. (1992). Failure of cerebral blood flow-metabolism coupling after acute subdural hematoma in the rat. Neurosurgery 31(6), 1062-1071.
15. LUERSSEN, T.G., KLAUBER, M.R., ET AL. (1988). Outcome from head injury related to patient's age. J. Neurosurg. 68, 409-416.
16. MILLER, J.D., BULLOCK, R., ET AL. (.1990). Ischemic brain damage in a model of acute subdural hematoma. Neurosurgery 27, 433-439.
17. PRINCE, D.A., and FEESER, H.R. (1988). Dextromethorphan protects against cerebral infarction in a rat model of hypoxiaischemia. Neurosci. Lett. 85, 291-296.
18. SCHMITT, B., NETZER, R., ET AL. (1994). Drug refractory epilepsy in brain damage: effect of dextromethorphan on EEG in four patients. J. Neurol. Neurosurg. Psychiat. 57(3), 333-339.
19. STEINBERG, G.K., and BELL, T. (1991). Clinical Dose-Escalation Safety Study of the NMDA Antagonist Dextromethorphan in Neurosurgical Patients. American Association of Neurological Surgeons. New Orleans,
20. STEINBERG, G.K., GEORGE, C.P., ET AL. (1988). Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits. Stroke 19, 1112-1118.
21. TORTELLA, F.C., MARTIN, D.A., ET AL. (1989). Dextromethorphan attenuates post-ischemia hypoperfusion following incomplete global ischemia in the anesthetized rat. Brain Res. 482, 179-183.
22. VAN RIJEN. P.C., VERHEUL, H.B., ET AL. (1991). Effects of dextromethorphan on rat brain during ischemia and reperfusion assessed by magnetic resonance spectroscopy. Stroke 22, 343-350.
23. WALKER, F.O., and HUNT, V.P. (1989). An open trial of dextromethorphan in Huntington's disease. Clin. Neuropharmacol. 12(4), 322-330.
24. WONG, B.Y., COULTER, D.A., ET AL. (1988). Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N-methyl-D-aspartate in brain slices. Neurosci. Lett. 85, 261-266.
25. YOON, Y.H., and MARMOR, M.F. (1989). Dextromethorphan protects retina against ischemic injury in vivo. Arch. Ophthalmol. 107, 409-411.